Article info
Clinical science
Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma
- Correspondence to Dr Nathalie Cassoux, Department of Surgical Oncology, Institut curie 26 rue d'Ulm, Paris 75005, France; nathalie.cassoux{at}curie.net
Citation
Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma
Publication history
- Received June 19, 2013
- Revised September 9, 2013
- Accepted September 15, 2013
- First published October 29, 2013.
Online issue publication
May 17, 2014
Article Versions
- Previous version (29 October 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/